A new study has shown that adding a drug called pembrolizumab to standard treatments can improve survival for people with certain sarcomas.

A rare form of cancer affecting bones and connective tissues ...

For patients with stage III undifferentiated pleomorphic sarcoma or dedifferentiated or pleomorphic liposarcoma of t ...

Adding a PD-1 inhibitor to standard of care improved disease-free survival (DFS) in stage III soft-tissue sarcoma of the ...

Discover how pembrolizumab, an immunotherapy drug, enhances disease-free survival in advanced soft tissue sarcoma, offering a ...

Early assessment of treatment response is crucial in patients with soft-tissue sarcoma. A prospective study has examined whether changes in tumor 18 F-fluorodeoxyglucose (FDG) uptake could predict ...

Sarcoma is another name for a malignant bone tumor. Bone cancer can spread to other parts of the body, like the lungs or lymph nodes. Treatment for bone cancer is based on the stage of the cancer ...